MERCK Kommanditgesells Ownership
| MKGAF Stock | USD 138.00 1.16 0.83% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
MERCK |
MERCK Pink Sheet Ownership Analysis
About 61.0% of the company shares are owned by institutional investors. The book value of MERCK Kommanditgesells was now reported as 64.91. The company recorded earning per share (EPS) of 8.58. MERCK Kommanditgesells last dividend was issued on the 25th of April 2022. The entity had 2:1 split on the 30th of June 2014. MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kgaa operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 62770 people.The quote for MERCK Kommanditgesellschaft auf is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about MERCK Kommanditgesellschaft auf contact Matthias Heinzel at 49 6151 72 0 or learn more at https://www.merckgroup.com.Currently Active Assets on Macroaxis
Other Information on Investing in MERCK Pink Sheet
MERCK Kommanditgesells financial ratios help investors to determine whether MERCK Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MERCK with respect to the benefits of owning MERCK Kommanditgesells security.